The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells
- 1 October 2002
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 367 (1) , 121-128
- https://doi.org/10.1042/bj20020439
Abstract
Extracellular purines are important signalling molecules in the vasculature that are regulated by a network of cell surface ectoenzymes. By using human endothelial cells and normal and leukaemic lymphocytes as enzyme sources, we identified the following purine-converting ectoenzymes: (1) ecto-nucleotidases, NTP diphosphohydrolase/CD39 (EC 3.6.1.5) and ecto-5'-nucleotidase/CD73 (EC 3.1.3.5); (2) ecto-nucleotide kinases, adenylate kinase (EC 2.7.4.3) and nucleoside diphosphate kinase (EC 2.7.4.6); (3) ecto-adenosine deaminase (EC 3.5.4.4). Evidence for this was obtained by using enzyme assays with (3)H-labelled nucleotides and adenosine as substrates, direct evaluation of gamma-phosphate transfer from [gamma-(32)P]ATP to AMP/NDP, and bioluminescent measurement of extracellular ATP synthesis. In addition, incorporation of radioactivity into an approx. 20 kDa surface protein was observed following incubation of Namalwa B cells with [gamma-(32)P]ATP. Thus two opposite, ATP-generating and ATP-consuming, pathways coexist on the cell surface, where basal ATP release, re-synthesis of high-energy phosphoryls, and selective ecto-protein phosphorylation are counteracted by stepwise nucleotide breakdown with subsequent adenosine inactivation. The comparative measurements of enzymic activities indicated the predominance of the nucleotide-inactivating pathway via ecto-nucleotidase reactions on the endothelial cells. The lymphocytes are characterized by counteracting ATP-regenerating/adenosine-eliminating phenotypes, thus allowing them to avoid the lymphotoxic effects of adenosine and maintain surrounding ATP at a steady-state level. These results are in agreement with divergent effects of ATP and adenosine on endothelial function and haemostasis, and provide a novel regulatory mechanism of local agonist availability for nucleotide- or nucleoside-selective receptors within the vasculature.Keywords
This publication has 33 references indexed in Scilit:
- Receptors for Purines and PyrimidinesPharmacological Reviews, 2025
- Effect of shear stress on the release of soluble ecto‐enzymes ATPase and 5′‐nucleotidase along with endogenous ATP from vascular endothelial cellsBritish Journal of Pharmacology, 2000
- Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes.1999
- Ecto-protein kinases: ecto-domain phosphorylation as a novel target for pharmacological manipulation?Trends in Pharmacological Sciences, 1999
- Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulationNature Medicine, 1999
- Detection of local ATP release from activated platelets using cell surface-attached firefly luciferaseAmerican Journal of Physiology-Cell Physiology, 1999
- P2 receptor subtypes in the cardiovascular systemBiochemical Journal, 1998
- Steady-state binding of [ 3 H]ATP to rat liver plasma membranes and competition by various purinergic agonists and antagonistsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1998
- Enzymatic and extraenzymatic role of ecto‐adenosine deaminase in lymphocytesImmunological Reviews, 1998
- Ecto‐enzyme and signaling functions of lymphocyte CD 7 3Immunological Reviews, 1998